Owner Boehringer Ingelheim (Canada) Ltd.

Inventors Thibeault, Diane; Pilote, Louise; Pause, Arnim; Lamarre, Daniel; Maurice, Roger

Agent Davies Collison Cave

Pub. Number AU-B-2002224688

PCT Pub. Number WO02/48375

Priority 60/256,031 15.12.00 US

Filing date 13 December 2001

Wipo publication date 24 June 2002

Acceptance publication date 8 March 2007

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 9/50 (2006.01) Enzymes, e.g. ligases (6.) - Proteinases

C12N 15/50 (2006.01) Mutation or genetic engineering

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids